Group Lifestyle Balance Program for Traumatic Brain Injury
Trial Summary
What is the purpose of this trial?
The purpose of this RCT is to examine the efficacy of a Group Lifestyle Balance™ (GLB) program adapted for people with traumatic brain injury (TBI) on primary (weight) and secondary outcomes at 3, 6, 12, and 18 months from enrollment into the program.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are currently taking medication for type 2 diabetes.
What data supports the effectiveness of the treatment Group Lifestyle Balance™ for traumatic brain injury?
Research shows that people with traumatic brain injury who participated in the Group Lifestyle Balance™ program lost an average of 17.8 pounds, which is about 7.9% of their body weight, compared to no weight loss in the control group. This suggests the program can effectively help manage weight in this population.12345
Is the Group Lifestyle Balance Program safe for people with traumatic brain injury?
How is the Group Lifestyle Balance Program for Traumatic Brain Injury different from other treatments for TBI?
The Group Lifestyle Balance Program for Traumatic Brain Injury is unique because it adapts a proven weight-loss and healthy lifestyle program specifically for people with TBI, focusing on weight management through healthy eating and physical activity. It is delivered via telehealth, making it accessible to those who may face barriers like living in rural areas or lacking transportation.12357
Research Team
Simon Driver, PhD
Principal Investigator
Baylor Scott & White Institute for Rehabilitation
Eligibility Criteria
This trial is for adults aged 18-64 who are at least 6 months post-traumatic brain injury (TBI), have a BMI of 25 or higher, and can use a smartphone or tablet. They must not be in certain care facilities, pregnant, have an eating disorder, low cognitive function, or conditions that make physical activity unsafe.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive the GLB-TBI intervention or attention control over a 12-month period, with 22 in-person or virtual group sessions.
App Integration
A smartphone application is integrated at week 12 to enhance participant engagement.
Follow-up
Participants are monitored for maintenance of weight and other secondary outcomes at 18 months.
Treatment Details
Interventions
- Attention Control Group
- Group Lifestyle Balance™
Find a Clinic Near You
Who Is Running the Clinical Trial?
Baylor Research Institute
Lead Sponsor
University of Texas Southwestern Medical Center
Collaborator
National Institute on Disability, Independent Living, and Rehabilitation Research
Collaborator